サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1663502

デジタルバイオマーカーの世界市場：種類別・用途別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Digital Biomarkers Market, By Type, By Application, By End-Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 280 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
デジタルバイオマーカーの世界市場：種類別・用途別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年01月04日
発行: AnalystView Market Insights
ページ情報: 英文 280 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

デジタルバイオマーカー市場規模は2024年に35億4,054万米ドルとなり、2025年から2032年にかけてCAGR 22.90%で拡大

デジタルバイオマーカーの市場力学

遠隔患者モニタリングへの注目の高まりが市場成長を牽引

遠隔患者モニタリング (RPM) への注目の高まりが、デジタルバイオマーカー市場を大きく牽引しています。RPMには、ウェアラブル、モバイルアプリケーション、センサーなどのデジタル技術を使用して、従来の臨床環境以外で患者の健康状態を監視することが含まれます。より患者中心のケアモデルへの移行や慢性疾患の増加に伴い、RPMによって医療提供者は患者の健康状態をリアルタイムで追跡できるようになり、タイムリーな介入や糖尿病、高血圧、心血管疾患などの疾患管理の改善につながります。RPMの普及を促進する主な要因の一つは、個別化された継続的医療に対する需要の高まりです。デジタルバイオマーカーは継続的でリアルタイムのデータを提供するため、よりオーダーメイドの治療が可能になり、患者の転帰が改善されます。米国保健社会福祉省によると、RPMは病院の再入院率を25%低下させ、訪問診療の必要性を減らすことで医療費を削減することが示されています。これは、患者ケアの改善と医療資源利用の最適化の両方におけるRPMの有効性を示しています。さらに、現在進行中のCOVID-19パンデミックは遠隔モニタリングの必要性を加速させており、患者や医療提供者は対面診療に代わるより安全な方法を求めています。慢性疾患の蔓延は、ウェアラブルデバイスの技術的進歩と相まって、デジタルバイオマーカー市場をさらに活性化させ、医療の未来を変革しています。

デジタルバイオマーカー市場：主な考察

  • 弊社リサーチアナリストの分析によると、世界市場は予測期間 (2025-2032年) に約22.90%のCAGRで毎年成長すると推定されます。
  • 種類別では、2024年には生理学的が最大の市場シェアを示すと予測されています。
  • 最終用途別では、2024年には医療提供者が主要セグメントとなりました。
  • 地域別では、北米が2024年に収益を生み出す主要市場です。

デジタルバイオマーカー市場：セグメンテーション分析

デジタルバイオマーカーの世界市場は、種類、用途、最終用途、地域によって区分されます。

市場は種類によって3つのカテゴリーに分けられます：生理的、行動的、認知的。生理学的バイオマーカーは、心拍数、血圧、体温などのバイタルサインをリアルタイムで正確に把握できるため、慢性疾患のモニタリングに不可欠であり、市場を独占しています。これらのバイオマーカーはウェアラブルデバイスや遠隔モニタリングソリューションに広く採用されており、個別化医療の要となっています。

市場は最終用途に基づき、医療提供者、製薬企業、研究機関の3つに分類されます。医療提供者は、患者のモニタリング、診断、治療の最適化にデジタルバイオマーカーを活用するという重要な役割を担っているため、市場を独占しています。これらの技術の採用は、リアルタイムのデータ追跡、疾患の早期発見、個別化された治療計画を可能にすることで患者ケアを強化し、市場成長を促進します。

デジタルバイオマーカー市場：地域別分析

デジタルバイオマーカー市場は地域差が大きく、北米は高度な医療インフラの存在、ウェアラブル技術の普及、デジタルヘルス・イニシアチブに対する政府支援の増加により市場をリードしています。米国は、慢性疾患の有病率の高さ、遠隔医療の進歩、医療イノベーションへの多額の投資により、最先端を走っています。さらに、21世紀治療法などの米国政府の政策がデジタルヘルスツールの使用を促進し、デジタルバイオマーカーの採用を後押ししています。欧州は、患者中心の医療と遠隔患者モニタリングを重視する傾向が強まっており、これに追随しています。ドイツや英国のような国では、個別化医療の強化や慢性疾患管理の改善を目指し、デジタルバイオマーカーの臨床への導入が進んでいます。アジア太平洋地域では、医療費の増加、慢性疾患管理に対する意識の高まり、技術の進歩により市場が急拡大しています。日本・中国・インドなどの国々では、増加する疾病負担を管理し、医療へのアクセスを改善するため、デジタルヘルス・ソリューションの導入が進んでいます。中東・アフリカ (MEA) も、デジタルヘルスの導入はまだ初期段階にあるもの、政府の支援や医療システムの改善によって勢いを増しているため、ペースは遅いもの、成長を目の当たりにしています。

デジタルバイオマーカー市場：競合情勢

デジタルバイオマーカー市場の競合情勢は、テクノロジー企業、医療提供者、研究機関など、多様なプレーヤーによって特徴付けられます。同分野の企業は、イノベーションと戦略的パートナーシップに注力し、サービスの拡充を図っています。主要企業は医療機関との提携を活用して、デジタルバイオマーカーを臨床ワークフローに統合し、患者のモニタリングや疾病管理における有用性を高めています。さらに、各社が市場での地位を強化し、技術力を高めようとしていることから、M&Aの動向も活発化しています。各社はまた、デジタルバイオマーカーの精度と予測力を向上させるため、高度なAIアルゴリズム、機械学習、データ解析を取り入れた製品開発にも注力しています。同市場は非常に細分化されており、技術の進歩、統合の容易さ、規制遵守、費用対効果などの要因で各社が競い合っています。個別化医療の重要性が高まる中、デジタルバイオマーカーは慢性疾患の管理に欠かせない要素になりつつあり、これが革新的ソリューションへの需要を後押ししています。また、ウェアラブルデバイス、モバイルアプリケーション、センサー技術の進歩により、新興企業の参入が相次いでおり、従来の企業は進化する医療情勢への対応を迫られています。

目次

第1章 デジタルバイオマーカー市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 デジタルバイオマーカーの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 デジタルバイオマーカー市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 デジタルバイオマーカー市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 デジタルバイオマーカーの市場情勢

  • デジタルバイオマーカーの市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 デジタルバイオマーカー市場：種類別

  • 概要
    • セグメント別シェア分析：種類別
    • 生理学的
    • 行動
    • 認知
    • その他

第8章 デジタルバイオマーカー市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • ウェアラブルデバイス
    • モバイルアプリケーション
    • 遠隔モニタリングシステム
    • センサー技術
    • その他

第9章 デジタルバイオマーカー市場：最終用途別

  • 概要
    • セグメント別シェア分析：最終用途別
    • 医療提供者
    • 製薬企業
    • 研究機関
    • その他

第10章 デジタルバイオマーカー市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋地域の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ (LATAM)
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ (MEA)
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：デジタルバイオマーカー業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Biofourmis, Inc.
    • Roche Holding AG
    • Koneksa Health, Inc.
    • Philips Healthcare
    • Abbott Laboratories
    • Google LLC
    • Biogen, Inc.
    • Garmin Ltd.
    • Apple Inc.
    • Medtronic PLC
    • Chrono Therapeutics, Inc.
    • Senseonics Holdings, Inc.
    • Proteus Digital Health, Inc.
    • Omron Healthcare Co., Ltd.
    • ActiGraph, LLC
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4690

REPORT HIGHLIGHT

Digital Biomarkers Market size was valued at US$ 3,540.54 Million in 2024, expanding at a CAGR of 22.90% from 2025 to 2032.

Digital biomarkers are measurable indicators of biological processes, conditions, or diseases, which are captured and tracked using digital technologies such as wearables, mobile apps, and remote monitoring devices. These biomarkers provide real-time, continuous, and objective data about an individual's health status. Unlike traditional biomarkers, which are often derived from blood samples or clinical tests, digital biomarkers offer a more dynamic and non-invasive way to monitor health. The need for digital biomarkers arises from the growing demand for personalized healthcare and early disease detection. Traditional clinical visits can be infrequent, leading to gaps in understanding a patient's condition. Digital biomarkers bridge this gap by enabling continuous monitoring, helping detect health issues before they manifest with severe symptoms. They also facilitate timely interventions, improving patient outcomes. The importance of digital biomarkers lies in their potential to revolutionize healthcare. They provide accurate, real-time insights into an individual's health, allowing for personalized treatment plans and enabling the monitoring of chronic conditions such as diabetes, cardiovascular diseases, and neurological disorders. Furthermore, digital biomarkers can enhance clinical trials, offering better data for assessing drug efficacy and safety. They are also crucial in promoting preventive care by tracking early signs of diseases, thus helping in proactive health management.

Digital Biomarkers Market- Market Dynamics

Increasing focus on remote patient monitoring to drive the market growth

The growing focus on remote patient monitoring (RPM) is significantly driving the Digital Biomarkers market. RPM involves the use of digital technologies, such as wearables, mobile applications, and sensors, to monitor patients' health status outside of traditional clinical settings. With the shift towards more patient-centric care models and the rise of chronic diseases, RPM enables healthcare providers to track patient health in real-time, leading to timely interventions and better management of conditions such as diabetes, hypertension, and cardiovascular diseases. One key factor driving RPM adoption is the increasing demand for personalized and continuous healthcare. Digital biomarkers provide continuous, real-time data, allowing for more tailored treatments and improving patient outcomes. According to the U.S. Department of Health and Human Services, RPM has been shown to reduce hospital readmission rates by 25% and lower healthcare costs by reducing the need for in-person visits. This demonstrates the effectiveness of RPM in both improving patient care and optimizing healthcare resource utilization. Moreover, the ongoing COVID-19 pandemic has accelerated the need for remote monitoring, with patients and healthcare providers seeking safer alternatives to in-person visits. The growing prevalence of chronic diseases, coupled with technological advancements in wearable devices, further fuels the market for digital biomarkers, transforming the future of healthcare.

Digital Biomarkers Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 22.90% over the forecast period (2025-2032)
  • Based on Type segmentation, Physiological was predicted to show maximum market share in the year 2024
  • Based on End-Use segmentation, Healthcare Providers was the leading segment in 2024
  • On the basis of region, North America was the leading revenue generator in 2024

Digital Biomarkers Market- Segmentation Analysis:

The Global Digital Biomarkers Market is segmented on the basis of Type, Application, End-Use and Region.

The market is divided into three categories based on Type: Physiological, Behavioral, Cognitive. Physiological biomarkers dominate the market due to their ability to provide real-time, accurate insights into vital signs like heart rate, blood pressure, and temperature, which are essential for monitoring chronic conditions. These biomarkers are widely adopted in wearable devices and remote monitoring solutions, making them a cornerstone of personalized healthcare.

The market is divided into three categories based on End-Use: Healthcare Providers, Pharmaceutical Companies, Research Organizations. Healthcare Providers dominate the market due to their critical role in utilizing digital biomarkers for patient monitoring, diagnosis, and treatment optimization. Their adoption of these technologies enhances patient care by enabling real-time data tracking, early disease detection, and personalized treatment plans, driving market growth.

Digital Biomarkers Market- Geographical Insights

The Digital Biomarkers market shows significant geographical variation, with North America leading the market due to the presence of advanced healthcare infrastructure, widespread adoption of wearable technologies, and increasing government support for digital health initiatives. The U.S. is at the forefront, driven by the high prevalence of chronic diseases, advancements in telemedicine, and substantial investments in healthcare innovation. Moreover, the U.S. government's policies, such as the 21st Century Cures Act, promote the use of digital health tools, boosting the adoption of digital biomarkers. Europe follows closely, driven by the region's growing emphasis on patient-centered healthcare and remote patient monitoring. Countries like Germany and the UK are increasingly integrating digital biomarkers into clinical practice, aiming to enhance personalized medicine and improve chronic disease management. In the Asia-Pacific region, the market is expanding rapidly due to increasing healthcare spending, growing awareness about chronic disease management, and technological advancements. Countries like Japan, China, and India are adopting digital health solutions to manage the rising burden of diseases and improve healthcare access. The Middle East and Africa (MEA) are also witnessing growth, albeit at a slower pace, as digital health adoption is still in the early stages but gaining momentum with government-backed initiatives and improving healthcare systems.

Digital Biomarkers Market- Competitive Landscape:

The competitive landscape of the Digital Biomarkers market is marked by a diverse range of players, including technology companies, healthcare providers, and research organizations. Companies in this space are focusing on innovation and strategic partnerships to expand their offerings. Key players are leveraging collaborations with healthcare institutions to integrate digital biomarkers into clinical workflows, enhancing their utility in patient monitoring and disease management. Moreover, there is a growing trend of mergers and acquisitions as companies seek to strengthen their market position and enhance their technological capabilities. Companies are also focusing on product development, incorporating advanced AI algorithms, machine learning, and data analytics to improve the accuracy and predictive power of digital biomarkers. The market is highly fragmented, with players competing on factors such as technological advancement, ease of integration, regulatory compliance, and cost-effectiveness. With the increasing importance of personalized healthcare, digital biomarkers are becoming a crucial component in managing chronic conditions, which drives the demand for innovative solutions. Additionally, the market is witnessing an influx of startups, driven by advancements in wearable devices, mobile applications, and sensor technologies, challenging traditional players to adapt to the evolving healthcare landscape.

Recent Developments:

  • In February 2024, Biofourmis secured four new agreements with top pharmaceutical companies, expanding its role in digital clinical trials and the development of digital biomarkers, particularly in oncology. The company's expertise in digital biomarkers and decentralized clinical trials is driving the adoption of its platform, which aims to reduce study timelines and enhance participant engagement through remote monitoring and in-home services.
  • In November 2024, Neuron23 partnered with Roche to utilize its digital biomarker and device as a primary endpoint in the Phase 2 NEULARK clinical trial for Parkinson's disease. The use of Roche's navify digital biomarker solution will enhance precision, reduce patient burden, and improve clinical trial efficiency by offering continuous, objective symptom tracking compared to traditional clinical rating scales.
  • In December 2024, Koneksa published a new data syndication model to enhance drug discovery by using digital health data for clinical and translational science. The model facilitates collaboration among stakeholders like biopharmaceutical companies, enabling faster study launches and real-time data sharing to validate digital health measures more efficiently. This approach is exemplified by the LEARNS study, which is evaluating Parkinson's disease progression using wearable devices and digital health tools to speed up the validation of digital biomarkers in clinical trials.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIGITAL BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Biofourmis, Inc.
  • Roche Holding AG
  • Koneksa Health, Inc.
  • Philips Healthcare
  • Abbott Laboratories
  • Google LLC
  • Biogen, Inc.
  • Garmin Ltd.
  • Apple Inc.
  • Medtronic PLC
  • Chrono Therapeutics, Inc.
  • Senseonics Holdings, Inc.
  • Proteus Digital Health, Inc.
  • Omron Healthcare Co., Ltd.
  • ActiGraph, LLC
  • Others

GLOBAL DIGITAL BIOMARKERS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Physiological
  • Behavioral
  • Cognitive
  • Others

GLOBAL DIGITAL BIOMARKERS MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Wearable Devices
  • Mobile Applications
  • Remote Monitoring Systems
  • Sensor Technologies
  • Others

GLOBAL DIGITAL BIOMARKERS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Healthcare Providers
  • Pharmaceutical Companies
  • Research Organizations
  • Others

GLOBAL DIGITAL BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Digital Biomarkers Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Digital Biomarkers Market Snippet by Type
    • 2.1.2. Digital Biomarkers Market Snippet by Application
    • 2.1.3. Digital Biomarkers Market Snippet by End-Use
    • 2.1.4. Digital Biomarkers Market Snippet by Country
    • 2.1.5. Digital Biomarkers Market Snippet by Region
  • 2.2. Competitive Insights

3. Digital Biomarkers Key Market Trends

  • 3.1. Digital Biomarkers Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Digital Biomarkers Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Digital Biomarkers Market Opportunities
  • 3.4. Digital Biomarkers Market Future Trends

4. Digital Biomarkers Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Digital Biomarkers Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Digital Biomarkers Market Landscape

  • 6.1. Digital Biomarkers Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Digital Biomarkers Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Physiological
    • 7.1.3. Behavioral
    • 7.1.4. Cognitive
    • 7.1.5. Others

8. Digital Biomarkers Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Wearable Devices
    • 8.1.3. Mobile Applications
    • 8.1.4. Remote Monitoring Systems
    • 8.1.5. Sensor Technologies
    • 8.1.6. Others

9. Digital Biomarkers Market - By End-Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2024 & 2032 (%)
    • 9.1.2. Healthcare Providers
    • 9.1.3. Pharmaceutical Companies
    • 9.1.4. Research Organizations
    • 9.1.5. Others

10. Digital Biomarkers Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Digital Biomarkers Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Digital Biomarkers Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Digital Biomarkers Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Digital Biomarkers Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Digital Biomarkers Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Digital Biomarkers Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Biofourmis, Inc.
    • 11.2.2. Roche Holding AG
    • 11.2.3. Koneksa Health, Inc.
    • 11.2.4. Philips Healthcare
    • 11.2.5. Abbott Laboratories
    • 11.2.6. Google LLC
    • 11.2.7. Biogen, Inc.
    • 11.2.8. Garmin Ltd.
    • 11.2.9. Apple Inc.
    • 11.2.10. Medtronic PLC
    • 11.2.11. Chrono Therapeutics, Inc.
    • 11.2.12. Senseonics Holdings, Inc.
    • 11.2.13. Proteus Digital Health, Inc.
    • 11.2.14. Omron Healthcare Co., Ltd.
    • 11.2.15. ActiGraph, LLC
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us